NPJ Vaccines

Autor: Wagstaffe, Helen R., Susannini, Giada, Thiébaut, Rodolphe, Richert, Laura, Lévy, Yves, Lévy, Yves, Bockstal, Viki, Stoop, Jeroen N., Luhn, Kerstin, Douoguih, Macaya, Riley, Eleanor M, Lacabaratz, Christine, Goodier, Martin R

Publikováno v: NPJ vaccines
NPJ vaccines, Nature Research 2021, 6 (1), pp.19. ⟨10.1038/s41541-021-00280-0⟩
NPJ vaccines, 2021, 6 (1), pp.19. ⟨10.1038/s41541-021-00280-0⟩

International audience; Natural killer (NK) cells are implicated among immune effectors after vaccination against viral pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen, adenovirus type 26.ZEBOV followed by modi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::116e7156fcb75942023c0fe80e6cda99
https://hal.archives-ouvertes.fr/hal-03158135/file/BPH_NPJV_2021_Wagstaffe.pdf